Table 2.
Inhibitor and protease variant | Kd (nM) | Kd ratioa | ΔH (kcal mol−1) | −TΔS (kcal mol−1) | ΔG (kcal mol−1) |
---|---|---|---|---|---|
APV | |||||
WT | 0.39 ± 0.20 | 1.0 | −7.3 ± 0.9 | −5.3 | −12.6 |
I50V/A71V | 0.88 ± 0.02 | 2.2 | −11.8 ± 0.3 | −0.3 | −12.1 |
I50L/A71V | 0.14 ± 0.02 | 0.4 | −9.5 ± 0.2 | −3.8 | −13.2 |
DRV | |||||
WT | 0.004 ± 0.002 | 1.0 | −12.1 ± 0.8 | −3.1 | −15.2 |
I50V/A71V | 0.067 ± 0.021 | 16.7 | −12.0 ± 0.6 | −1.6 | −13.6 |
I50L/A71V | 0.016 ± 0.001 | 4.0 | −13.4 ± 0.9 | −1.1 | −14.5 |
ATV | |||||
WT | 0.23 ± 0.12 | 1.0 | −1.1 ± 0.2 | −11.8 | −12.9 |
I50V/A71V | 0.03 ± 0.01 | 0.1 | −7.3 ± 1.1 | −6.6 | −13.9 |
I50L/A71V | 0.65 ± 0.05 | 2.8 | −3.6 ± 0.4 | −8.7 | −12.3 |
Fold change with respect to WT protease.